Publications
Knowledge generated at IrsiCaixa is shared with the scientific community through the publication of articles in high impact scientific journals.
![Imatge de Publicacions](/sites/default/files/styles/3_1_small/public/2022-11/Portada_publicacions-petita_0.jpg?h=c6980913&itok=oZMso2V6)
A wide range of NS3/4A protease catalytic efficiencies in HCV-infected individuals.
[Position of darunavir in antiretroviral therapy].
Transient treatment exclusively containing nucleoside analogue reverse transcriptase inhibitors in highly antiretroviral-experienced patients preserves viral benefit when a fully active therapy was initiated.
Fumarate and nitrate reduction (FNR) dependent activation of the Escherichia coli anaerobic ribonucleotide reductase nrdDG promoter.
Once- or twice-daily dosing of nevirapine in HIV-infected adults: a population pharmacokinetics approach.
The host-dependent interaction of alpha-importins with influenza PB2 polymerase subunit is required for virus RNA replication.
Clinical approach to drug resistance interpretation: expert advice.
Evolution of drug resistance in HIV-infected patients remaining on a virologically failing combination antiretroviral therapy regimen.
The safety of tenofovir disoproxil fumarate for the treatment of HIV infection in adults: the first 4 years.
Monitoring atazanavir concentrations with boosted or unboosted regimens in HIV-infected patients in routine clinical practice.